| # | Title | Journal | Year | Citations |
|---|
| 1 | α1 -, α2 - and β-adrenoceptors in the urinary bladder, urethra and prostate | British Journal of Pharmacology | 2006 | 386 |
| 2 | Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors | Naunyn-Schmiedeberg's Archives of Pharmacology | 2008 | 139 |
| 3 | Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites | British Journal of Pharmacology | 2004 | 134 |
| 4 | Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors | Naunyn-Schmiedeberg's Archives of Pharmacology | 2009 | 131 |
| 5 | Sphingosine-1-phosphate signaling in the cardiovascular system | Current Opinion in Pharmacology | 2007 | 125 |
| 6 | Effects of ??1-Adrenoceptor Antagonists on Male Sexual Function | Drugs | 2006 | 119 |
| 7 | Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target | Neurourology and Urodynamics | 2011 | 115 |
| 8 | ASSOCIATION OF HYPERTENSION WITH SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA | Journal of Urology | 2004 | 108 |
| 9 | Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome | Expert Opinion on Pharmacotherapy | 2008 | 105 |
| 10 | Rho kinase: a target for treating urinary bladder dysfunction? | Trends in Pharmacological Sciences | 2006 | 90 |
| 11 | Neurotrophins as regulators of urinary bladder function | Nature Reviews Urology | 2012 | 78 |
| 12 | Drug-Induced Urinary Incontinence | Drugs and Aging | 2008 | 73 |
| 13 | Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy | Neuropsychopharmacology | 2009 | 73 |
| 14 | Does Cyclic AMP Mediate Rat Urinary Bladder Relaxation by Isoproterenol? | Journal of Pharmacology and Experimental Therapeutics | 2005 | 70 |
| 15 | Cyclic AMP-dependent and Epac-mediated Activation of R-Ras by G Protein-coupled Receptors Leads to Phospholipase D Stimulation | Journal of Biological Chemistry | 2006 | 68 |
| 16 | Basic Mechanisms of Urgency: Preclinical and Clinical Evidence | European Urology | 2009 | 66 |
| 17 | How valid are animal models to evaluate treatments for pulmonary hypertension? | Naunyn-Schmiedeberg's Archives of Pharmacology | 2006 | 64 |
| 18 | Do α1‐adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? | Neurourology and Urodynamics | 2008 | 61 |
| 19 | Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder | Naunyn-Schmiedeberg's Archives of Pharmacology | 2006 | 56 |
| 20 | The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS®) | European Urology Supplements | 2005 | 55 |
| 21 | Pharmacokinetics and Pharmacodynamics of Tamsulosin in its Modified-Release and Oral Controlled Absorption System Formulations | Clinical Pharmacokinetics | 2010 | 55 |
| 22 | Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder | Naunyn-Schmiedeberg's Archives of Pharmacology | 2005 | 54 |
| 23 | Safety of Telmisartan in Patients with Arterial Hypertension | Drug Safety | 2004 | 53 |
| 24 | Effects of muscarinic receptor stimulation on Ca2+ transient, cAMP production and pacemaker frequency of rabbit sinoatrial node cells | Basic Research in Cardiology | 2010 | 51 |
| 25 | Signal transduction and regulation: Are all α1-adrenergic receptor subtypes created equal? | Biochemical Pharmacology | 2007 | 50 |
| 26 | Pharmacologic Treatment of Male Stress Urinary Incontinence: Systematic Review of the Literature and Levels of Evidence | European Urology | 2008 | 50 |
| 27 | α1‐Adrenoceptors and ejaculatory function | British Journal of Pharmacology | 2007 | 44 |
| 28 | Comparison of Symptom Severity and Treatment Response in Patients with Incontinent and Continent Overactive Bladder | European Urology | 2005 | 43 |
| 29 | Sphingosine Kinase–Dependent Activation of Endothelial Nitric Oxide Synthase by Angiotensin II | Arteriosclerosis, Thrombosis, and Vascular Biology | 2006 | 42 |
| 30 | Medical Expulsive Therapy for Distal Ureteral Stones | Drugs | 2009 | 42 |
| 31 | Do gene polymorphisms alone or in combination affect the function of human β3‐adrenoceptors? | British Journal of Pharmacology | 2009 | 41 |
| 32 | Effect of pre-contraction on β-adrenoceptor-mediated relaxation of rat urinary bladder | World Journal of Urology | 2009 | 39 |
| 33 | Tissue functions mediated by β3-adrenoceptors—findings and challenges | Naunyn-Schmiedeberg's Archives of Pharmacology | 2010 | 39 |
| 34 | More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease | Journal of Muscle Research and Cell Motility | 2010 | 38 |
| 35 | In vivo studies on the effects of α1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits | Naunyn-Schmiedeberg's Archives of Pharmacology | 2006 | 37 |
| 36 | Role of serotonin and noradrenaline in stress urinary incontinence | BJU International | 2004 | 36 |
| 37 | Role of muscarinic receptor antagonists in urgency and nocturia | BJU International | 2005 | 36 |
| 38 | Specificity evaluation of antibodies against human β3-adrenoceptors | Naunyn-Schmiedeberg's Archives of Pharmacology | 2012 | 35 |
| 39 | Expression profiling of G‐protein‐coupled receptors in human urothelium and related cell lines | BJU International | 2012 | 34 |
| 40 | Autonomic nervous control of the urinary bladder | Acta Physiologica | 2013 | 33 |
| 41 | Identification and Characterization of Circulating Variants of CXCL12 from Human Plasma: Effects on Chemotaxis and Mobilization of Hematopoietic Stem and Progenitor Cells | Stem Cells and Development | 2014 | 32 |
| 42 | Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients | Neurourology and Urodynamics | 2007 | 31 |
| 43 | G‐protein βγ subunits in vasorelaxing and anti‐endothelinergic effects of calcitonin gene‐related peptide | British Journal of Pharmacology | 2012 | 31 |
| 44 | A rapid and validated HPLC method to quantify sphingosine 1-phosphate in human plasma using solid-phase extraction followed by derivatization with fluorescence detection | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences | 2005 | 30 |
| 45 | Does Phospholipase C Mediate Muscarinic Receptor-Induced Rat Urinary Bladder Contraction? | Journal of Pharmacology and Experimental Therapeutics | 2007 | 30 |
| 46 | Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk | BJU International | 2007 | 30 |
| 47 | Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation | European Urology Supplements | 2005 | 29 |
| 48 | Muscarinic receptor antagonists for overactive bladder treatment: does one fit all? | Current Opinion in Urology | 2009 | 29 |
| 49 | Lack of evidence that nebivolol is a β3-adrenoceptor agonist | European Journal of Pharmacology | 2011 | 29 |
| 50 | The Neuro-Urological Connection | European Urology Supplements | 2005 | 28 |
